Q1 2025 Holdings
Filed 2025-05-15 | 96 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $104.0M | 175,750 | 6.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $93.7M | 113,500 | 5.4% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $89.2M | 1,007,569 | 5.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $55.2M | 166,698 | 3.2% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $52.6M | 100,500 | 3.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $52.3M | 2,921,196 | 3.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $50.5M | 102,000 | 2.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $50.5M | 1,394,434 | 2.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $45.7M | 171,000 | 2.6% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $45.3M | 1,281,640 | 2.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $44.2M | 834,188 | 2.5% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $42.9M | 951,765 | 2.5% |
| Merus N V | COM | N5749R100 | $41.3M | 980,751 | 2.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $39.4M | 515,900 | 2.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $38.7M | 143,250 | 2.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $33.7M | 216,000 | 1.9% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $32.7M | 904,592 | 1.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $31.3M | 931,681 | 1.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $30.9M | 279,000 | 1.8% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $30.3M | 427,532 | 1.7% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $30.1M | 6,950,000 | 1.7% |
| Phreesia Inc(PHR) | COM | 71944F106 | $29.4M | 1,148,336 | 1.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $27.9M | 277,000 | 1.6% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $27.2M | 672,759 | 1.6% |
| Dexcom Inc(DXCM) | COM | 252131107 | $27.2M | 397,650 | 1.6% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $26.6M | 254,300 | 1.5% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $25.5M | 2,695,700 | 1.5% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $24.5M | 761,541 | 1.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $21.7M | 794,437 | 1.2% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $20.8M | 480,000 | 1.2% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $20.7M | 681,100 | 1.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $19.6M | 1,132,979 | 1.1% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $19.2M | 995,000 | 1.1% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $18.5M | 255,000 | 1.1% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $18.2M | 354,376 | 1.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $17.5M | 130,000 | 1.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $17.4M | 512,932 | 1.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $16.7M | 975,803 | 1.0% |
| Azenta Inc(AZTA) | COM | 114340102 | $16.5M | 475,000 | 0.9% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $15.8M | 99,250 | 0.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $15.6M | 1,909,362 | 0.9% |
| Warby Parker Inc(WRBY) | CL A COM | 93403J106 | $15.2M | 835,000 | 0.9% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $15.0M | 6,684,247 | 0.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $14.7M | 812,653 | 0.8% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $13.8M | 1,050,000 | 0.8% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $13.5M | 60,250 | 0.8% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $12.5M | 520,796 | 0.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $12.1M | 58,800 | 0.7% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $11.0M | 536,111 | 0.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $10.2M | 159,300 | 0.6% |